Special studies/analysis- medical/health

Ended Purchase Order Awarded Last action

Contract number
HHSN268201300238P
Awardee
Awarding agency
Obligated
$39,464

Award facts

Contract value 100% obligated
$39,464.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · Nhgri - UDP - mutation ATP1A3 analysis -$2
Original award $39,466

About this award

The National Heart, Lung, and Blood Institute awarded a purchase order to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 11, 2013, with a ceiling value of $39,464.00 for special studies and analysis of ATP1A3 mutation data related to medical and health research.

Work is performed in Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of September 29, 2014. No set-aside was used.

Quick answers

Who was awarded contract HHSN268201300238P?

HHSN268201300238P was awarded to The General Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 11, 2013.

How much is contract HHSN268201300238P worth?

The government has obligated $39,464 on HHSN268201300238P.

Was contract HHSN268201300238P competed?

The extent of competition for HHSN268201300238P was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award